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The advances in our knowledge of renal hyper-
tension over the last 75 years represents outstanding 
accomplishments in experimental and clinical medi-
cine. A review of the highlights of this important 
investigation in hypertension should begin with 
Tigerstedt and Bergman's work in Scandinavia which 
demonstrated in 1898, that extracts of kidney pos-
sessed a hypertensive action. They gave the name 
"renin" to the impure substance which produced this 
effect. For the next 30 years much work was done 
on the vasoconstrictor action of extracts of the 
adrenal medulla, the nervous system and the kidney. 
At the height of the depression, Harry Gold-
blatt, with a few hundred dollars, began his investi-
gations on the production of hypertension. His 
classical report in 1934 gave investigators an easy 
method of producing permanent renal hypertension. 
He used a tiny adjustable silver clip on the renal 
artery of dogs to produce partial or incomplete 
ischemia of the kidney. His work was confirmed 
promptly by many others. 
In 1938, Fasciolo, Houssay and Taquini in 
Argentina, by cross-venous techniques, demonstrated 
that the ischemic kidney produced a hypertensive 
substance, renin. In 1939, Braun Menendez and 
his group in Argentina extracted a substance which 
they called hypertensin, produced by the incubation of 
renin with plasma globulin or hypertensinogen. Page 
and Helmer, almost simultaneously in the United 
States, reached similar conclusions but used different 
terminology, renin plus renin activator produces 
angiotonin. 
Over the next 15 years much work was done 
on these extracts and enzymes. Finally, a decapeptide 
substance was identified. In 1956, Skeggs showed 
that a converting enzyme made the substance an 
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active vasopressor material by splitting off two amino 
acids. 
A year later, Bumpus in the United States and 
Rittel in Switzerland synthesized angiotonin or hy-
pertensin, depending on which group was involved. 
A year later, Page and Braun Menendez got together 
and came up with the bastard term-angiotensin. 
Levels of renin activity in patients were determined 
by the bioassay technique perfected by Gunnels until 
1969, when Haber described a practical radioim-
mune assay for angiotensin which has gained wide 
acceptance by the medical profession. 
On the clinical side, Butler in 1937, published 
the first report of nephrectomy for unilateral pyelo-
nephritis with relief of hypertension. This began the 
era of nephrectomy for all sorts of diseases with the 
hope of relieving hypertension. In 1939, Blackman 
examined at time of autopsy renal arteries of 50 pa-
tients with so-called hypertension. A high percentage 
of arteries (87 % ) had arteriosclerotic plaques and 
54% were found to have severe stenosis. This re-
port was not accepted at the time by the profession. 
In 1944, Yuile classified renal artery obstruction 
occlusive disease into extrinsic and intrinsic types. 
Finally in 1948, after many years of indiscriminate 
renal sacrifice, Homer Smith laid down the criteria 
for cure of hypertension, 145/ 90, and this closed 
the era of imprecise diagnosis oi renal hypertension. 
In 1950, Parke Smith and Arthur Evans in 
Cincinnati published a large series of translumbar 
aortograms with a low incidence of complications, 
resulting in a wave of popularity for aortography by 
urologists and later vascular surgeons. Up to that 
time, it had not been widely accepted by the medical 
profession in the United States. In 1952, at the 
Cleveland Clinic, we began to apply aortography in 
hypertensive patients. In 1954, Freeman and his 
associates reported the first case of endarterectomy 
of the renal artery with relief of hypertension. In 
1954, Howard and his colleagues at Johns Hopkins 
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published their classical report of cure of hyperten-
sion by nephrectomy. They called attention to the 
importance of careful scrutiny of the intravenous 
pyelogram for renal atrophy and to the fact that 
urine from the affected kidney had a lower sodium 
concentration and lower urine volume. 
In 19 5 7, the first report on the use of homo-
grafts for correcting fibromuscular hyperplasia of 
the renal artery appeared. Since then many tech-
niques have evolved for the correction of all kinds of 
renal artery disease. 
Renin is a proteolytic enzyme with a molecular 
weight of about 40,000. Its only known activity is 
to break a specific leucine-leucine bond on renin 
substrate produced in the liver. Renin originates in 
the granular cells surrounding afferent arterioles ad-
jacent to renal glomeruli. These juxtaglomerular 
cells, along with a few specialized distal tubular cells 
(macula densa) in the same region, form the juxta-
glomerular apparatus. This structure may be con-
sidered a combination baroceptor and sodium 
sensor. 
After renin acts on the substrate, angioten-
sin I is formed. As it passes through the circulation, 
it is acted on by the converting enzyme to form 
angiotensin II, the vasoconstrictor material causing 
arterial constriction and hypertension. Angiotensin 
II is also a major stimulus for aldosterone secretion 
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by the adrenal gland, providing a feedback mechan-
ism and completing the cycle initiated by renin 
release. Renin is inactivated in the liver, and angio-
tensin II is probably inactivated at its receptive sites. 
This is a dynamic, rapidly responding circuit. Renin 
is released within a few minutes after appropriate 
stimulation. Decline is equally rapid. Among r~cent 
discoveries, plasma and tissue enzymes have been 
found to exist which are capable of degrading angio-
tensin I and II to form a hectopeptide which exerts 
a powerful influence on the adrenal cortex to secrete 
aldosterone and preserve sodium. 
We have used Haber's radio-immune assay 
technique for the last two and one-half years in Dr. 
Wan's biochemical laboratory at Norfolk General 
Hospital. This is a specific assay for angiotensin I 
generation rate, which in most situations provides a 
correct measurement of renin activity. Nearly 400 
measurements of plasma renin activity were made 
between August 1970 and December 1971; over 900 
determinations, which included 56 bilateral renal 
vein determinations, were done in 1972. Approxi-
mately 20 patients were selected for operation in 
1972. In the first two months of 1973, we have 
operated on nine patients who have had this investi-
gation recently at Norfolk General Hospital, reflect-
ing in part the increased interest in renal hyperten-
sion since the use of renin assays on a wide scale. 
